TP53 and intrahepatic cholangiocarcinoma: The expression of oncogenes KRAS, IDH1, IDH2 and tumor suppressor gene TP53 showed no difference in HBV (+) ICC and HBV (-) ICC tumor tissues, indicating that there was no significant differences in gene mutations between the two ICC with different origins.